Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have been assigned a consensus rating of “Strong Buy” from the five ratings firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a strong buy rating.
A number of research firms have recently issued reports on HIV. Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Finally, Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, March 7th.
Get Our Latest Stock Analysis on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- What is a Secondary Public Offering? What Investors Need to Know
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- The How and Why of Investing in Gold Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Conference Calls and Individual Investors
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
